Bupropion and other non-nicotine pharmacotherapies.
University of Nottingham, Nottingham.
Elin
E
Roddy
D000280:Administration, Inhalation; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016642:Bupropion / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D018765:Dopamine Uptake Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004347:Drug Interactions; D006801:Humans; D008464:Mecamylamine / Q000627:therapeutic use; D009538:Nicotine / Q000008:administration & dosage; D018733:Nicotinic Antagonists / Q000627:therapeutic use; D016540:Smoking Cessation / Q000379:methods*
D000316:Adrenergic alpha-Agonists; D018687:Antidepressive Agents, Second-Generation; D018765:Dopamine Uptake Inhibitors; D018733:Nicotinic Antagonists; D016642:Bupropion; D008464:Mecamylamine; D009538:Nicotine; D003000:Clonidine